BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37723181)

  • 21. Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes.
    Zhang H; Chen L; Cai SH; Cheng H
    Leuk Res; 2016 Jul; 46():37-44. PubMed ID: 27123832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrysin modulates protein kinase IKKε/TBK1, insulin sensitivity and hepatic fatty infiltration in diet-induced obese mice.
    Amir Siddiqui M; Badruddeen ; Akhtar J; Uddin S; Chandrashekharan SM; Ahmad M; Khan MI; Khalid M
    Drug Dev Res; 2022 Feb; 83(1):194-207. PubMed ID: 34350600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.
    Gatot JS; Gioia R; Chau TL; Patrascu F; Warnier M; Close P; Chapelle JP; Muraille E; Brown K; Siebenlist U; Piette J; Dejardin E; Chariot A
    J Biol Chem; 2007 Oct; 282(43):31131-46. PubMed ID: 17823124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
    Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC
    J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages.
    Solis M; Romieu-Mourez R; Goubau D; Grandvaux N; Mesplede T; Julkunen I; Nardin A; Salcedo M; Hiscott J
    Eur J Immunol; 2007 Feb; 37(2):528-39. PubMed ID: 17236232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
    Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
    Zhou Z; Qi J; Lim CW; Kim JW; Kim B
    Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vimentin inhibits type I interferon production by disrupting the TBK1-IKKε-IRF3 axis.
    Liu H; Ye G; Liu X; Xue M; Zhou Q; Zhang L; Zhang K; Huang L; Weng C
    Cell Rep; 2022 Oct; 41(2):111469. PubMed ID: 36223739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKKε and TBK1 expression in gastric cancer.
    Lee SE; Hong M; Cho J; Lee J; Kim KM
    Oncotarget; 2017 Mar; 8(10):16233-16242. PubMed ID: 27145266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of endogenous regulation of the type I interferon response by suppressor of IκB kinase epsilon (SIKE), a novel substrate of TANK-binding kinase 1 (TBK1).
    Marion JD; Roberts CF; Call RJ; Forbes JL; Nelson KT; Bell JE; Bell JK
    J Biol Chem; 2013 Jun; 288(25):18612-23. PubMed ID: 23649622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer.
    Ritter JL; Zhu Z; Thai TC; Mahadevan NR; Mertins P; Knelson EH; Piel BP; Han S; Jaffe JD; Carr SA; Barbie DA; Barbie TU
    Cancer Res; 2020 Jan; 80(1):44-56. PubMed ID: 31662325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
    Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
    EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
    Sui C; Xiao T; Zhang S; Zeng H; Zheng Y; Liu B; Xu G; Gao C; Zhang Z
    J Immunol; 2022 Feb; 208(3):753-761. PubMed ID: 34996837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of TBK1 and IKKε in the expression and activation of Pellino 1.
    Smith H; Liu XY; Dai L; Goh ET; Chan AT; Xi J; Seh CC; Qureshi IA; Lescar J; Ruedl C; Gourlay R; Morton S; Hough J; McIver EG; Cohen P; Cheung PC
    Biochem J; 2011 Mar; 434(3):537-48. PubMed ID: 21204785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.
    Civas A; Génin P; Morin P; Lin R; Hiscott J
    J Biol Chem; 2006 Feb; 281(8):4856-66. PubMed ID: 16380379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1.
    Xiang W; Zhang Q; Lin X; Wu S; Zhou Y; Meng F; Fan Y; Shen T; Xiao M; Xia Z; Zou J; Feng XH; Xu P
    Sci Adv; 2016 Jul; 2(7):e1501889. PubMed ID: 27419230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxiredoxin 1 Interacts with TBK1/IKKε and Negatively Regulates Pseudorabies Virus Propagation by Promoting Innate Immunity.
    Lv L; Bai J; Gao Y; Jin L; Wang X; Cao M; Liu X; Jiang P
    J Virol; 2021 Sep; 95(19):e0092321. PubMed ID: 34260286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Metapneumovirus Induces IRF1
    Loevenich S; Spahn AS; Rian K; Boyartchuk V; Anthonsen MW
    Front Immunol; 2021; 12():563336. PubMed ID: 34248923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer.
    Bishop RT; Marino S; de Ridder D; Allen RJ; Lefley DV; Sims AH; Wang N; Ottewell PD; Idris AI
    Cancer Lett; 2019 May; 450():76-87. PubMed ID: 30790681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.